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ABSTRACT: Visualization and quantification of the adverse effects 
of distorted blood flow are important emerging fields in cardiology. 
Abnormal blood flow patterns can be seen in various cardiovascular 
diseases and are associated with increased energy loss. These adverse 
energetics can be measured and quantified using 3-dimensional 
blood flow data, derived from computational fluid dynamics and 
4-dimensional flow magnetic resonance imaging, and provide new, 
promising hemodynamic markers. In patients with palliated single-
ventricular heart defects, the Fontan circulation passively directs 
systemic venous return to the pulmonary circulation in the absence of 
a functional subpulmonary ventricle. Therefore, the Fontan circulation 
is highly dependent on favorable flow and energetics, and minimal 
energy loss is of great importance. A focus on reducing energy loss led 
to the introduction of the total cavopulmonary connection (TCPC) as 
an alternative to the classical Fontan connection. Subsequently, many 
studies have investigated energy loss in the TCPC, and energy-saving 
geometric factors have been implemented in clinical care. Great advances 
have been made in computational fluid dynamics modeling and can 
now be done in 3-dimensional patient-specific models with increasingly 
accurate boundary conditions. Furthermore, the implementation of 
4-dimensional flow magnetic resonance imaging is promising and can be 
of complementary value to these models. Recently, correlations between 
energy loss in the TCPC and cardiac parameters and exercise intolerance 
have been reported. Furthermore, efficiency of blood flow through 
the TCPC is highly variable, and inefficient blood flow is of clinical 
importance by reducing cardiac output and increasing central venous 
pressure, thereby increasing the risk of experiencing the well-known 
Fontan complications. Energy loss in the TCPC will be an important new 
hemodynamic parameter in addition to other well-known risk factors 
such as pulmonary vascular resistance and can possibly be improved 
by patient-specific surgical design. This article describes the theoretical 
background of mechanical energy of blood flow in the cardiovascular 
system and the methods of calculating energy loss, and it gives an 
overview of geometric factors associated with energy efficiency in the 
TCPC and its implications on clinical outcome. Furthermore, the role of 
4-dimensional flow magnetic resonance imaging and areas of future 
research are discussed.
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Cardiology is flow.
1 The primary goal of the car-
diovascular system is to drive, regulate, and 
maintain adequate blood flow throughout the 
body.1 Blood flows because potential pressure energy 
(systolic blood pressure), predominantly generated by 
the ventricles, is converted into kinetic energy (ie, veloc-
ity) along its course through the body.2 The ventricles 
must provide the flowing blood with enough energy 
to overcome the unavoidable frictional loss of energy 
throughout the circulation.2 Energy-consuming abnor-
mal blood flow patterns (eg, flow separation, flow col-
lision, or helical flow)3 caused by abnormal geometry 
(eg, vessel/valve stenosis or vessel aneurysms) provide 
an increased working load to the ventricles to maintain 
adequate flow throughout the cardiovascular system, 
which may ultimately result in heart failure.4 Further-
more, blood flow induces mechanical forces on the ves-
sel wall. Abnormal values of these forces, for example, 
wall shear stress, have been identified in diseases such 
as atherosclerosis and aortic aneurysms.1,5
The degree of energy loss, and thereby its hemody-
namic impact, is conventionally assessed with indirect, 
global parameters, such as vessel size, pressure gradi-
ents or effective orifice area, which may lead to inac-
curate disease severity characterization.2,4–6 Although 
visualization and direct measurement of 3-dimensional 
(3D) blood flow have long been elusive goals, emerg-
ing techniques such as four-dimensional flow magnetic 
resonance imaging (4D flow MRI) and patient-specific 
computational fluid dynamics (CFD) models are provid-
ing unprecedented, unique insights into physiological 
and pathophysiological flow in the human circulation. 
These techniques provide a time-resolved (ie, during 
a cardiac cycle) 3D velocity vector field (from 4D flow 
MRI) or a combined velocity and pressure field (from 
CFD).5,7,8 Using these techniques, complex intracardiac 
and vascular flow patterns, including vortex formation 
and helical flow, have been identified in various cardio-
vascular diseases, including ischemic and dilated cardio-
myopathies, aortic disease, valvular disease, and con-
genital heart disease.6,7,9,10 Moreover, these techniques 
allow direct quantification of the energetics of the 3D, 
time-resolved blood flow data that lead to new hemo-
dynamic parameters, such as viscous energy loss, turbu-
lent kinetic energy, wall shear stress and kinetic energy.8 
Direct measurement of viscous energy loss (laminar 
flow) or turbulent kinetic energy (turbulent flow) in 
patients with aortic valve disease or aortic dilatation 
also takes the hemodynamic impact of the abnormal, 
energy-consuming flow patterns in the ascending aorta 
and aortic arch into account and may therefore better 
reflect disease severity complementary to conventional 
parameters.6,11 The definitive role of these and other 
new energetic markers of blood flow in clinical deci-
sion making in various types of cardiovascular disease is 
promising and subject to future studies.
In patients with palliated single-ventricular heart de-
fects, the Fontan circulation passively directs system-
ic venous return to the pulmonary circulation in the 
absence of a functional subpulmonary ventricle. The 
Fontan circulation is especially dependent on favor-
able flow and energetics, and minimal energy loss is 
of great importance. Minimizing energy loss, via the 
rationale that an energy-efficient total cavopulmonary 
connection (TCPC) leads to reduced central venous 
pressure and increased preload, and therefore cardiac 
output, aims to decrease the risk of well-known Fon-
tan complications such as exercise intolerance, heart 
failure, protein-losing enteropathy, venovenous collat-
eral formation, or liver fibrosis/cirrhosis.12,13 The con-
cept and clinical implications of adverse energetics in 
patients with a Fontan circulation are the subject of 
this article, including the theoretical background and 
methods of calculating energy loss, factors associated 
with increased/reduced energy loss and the correlation 
with clinical parameters.
THE FONTAN PROCEDURE
The Fontan procedure is the current standard palliative 
treatment of children with a functional univentricular 
heart. It creates a circulation system in which systemic 
venous return enters the pulmonary circulation passive-
ly, without the support of a cardiac ventricle. Originally, 
the procedure incorporated the right atrium into the 
design in a so-called atriopulmonary connection, with 
the rationale that contraction of the atrium can add 
forward energy to the otherwise passive flow entering 
the lungs. However, in a landmark in vitro study by de 
Leval et al,14 it was shown that by incorporating a pul-
satile atrium, turbulent flow inside this atrium led to in-
creased rather than decreased energy loss, and the im-
portance of energy efficiency was emphasized. It led to 
the recommendation of the TCPC, and subsequently its 
superiority over the atriopulmonary connection in terms 
of efficiency was demonstrated.14–16 Today, the Fontan 
circulation is created in a staged approach. Most often 
a bidirectional cavopulmonary connection is performed 
by connecting the superior vena cava (SVC) end to side 
to the right pulmonary artery (RPA) at 6 to 12 months 
of age (Glenn), with completion of the Fontan circula-
tion (TCPC) using an intraatrial lateral tunnel or extra-
cardiac conduit (ECC) technique at 3 to 5 years of age. 
Some centers use the so-called hemi-Fontan procedure 
instead of the Glenn procedure, in which the SVC is not 
disconnected from the right atrium, but instead a patch 
reconstruction is performed between the medial side of 
the SVC, the right atrium, and the RPA. A second patch 
at the superior cavo-atrial junction prevents the blood 
flow from the inferior vena cava (IVC) from entering the 
PAs. With completion of the TCPC, this latter patch is 
removed and an intraatrial lateral tunnel is constructed, 
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allowing IVC flow toward the PAs. Therefore, final ge-
ometry and flow characteristics between patients with 
an intraatrial lateral tunnel Fontan after Glenn or Hemi-
Fontan are inherently different.
The TCPC has 2 important tasks: it has to (1) be as en-
ergy efficient as possible, and (2) distribute hepatic blood 
to both lungs.17 Adding IVC blood to the SVC flow from 
the bidirectional Glenn shunt makes for an almost com-
plete separation of the pulmonary and systemic circula-
tions. Only venous blood from the coronary circulation re-
mains entering into the systemic circulation. Furthermore, 
IVC blood contains the important hepatic factor. A lack 
of this hepatic factor is associated with the formation of 
pulmonary arteriovenous malformations because a high 
prevalence has been reported after a Glenn shunt or a 
Kawashima procedure, with reduction of these pulmo-
nary arteriovenous malformations after reincorporation 
of the hepatic veins into the Fontan circulation.18 
Although short-term outcome after the Fontan pro-
cedure has improved considerably since its introduction 
in 1971,12 long-term morbidity and mortality remain 
significant, including a generally limited exercise toler-
ance.13,19
Blood flow to the pulmonary vasculature in a patient 
with a Fontan is mainly driven by increased systemic ve-
nous pressure, which is formed by the remaining ener-
gy generated by the heart, the peripheral muscle pump, 
and intrathoracic pressure changes during respiration.20 
Because of the assumed importance of minimizing 
energy loss, the TCPC has been an area of extensive 
research. This has been done mainly via in vitro mod-
els,9,14,21–34 CFD models,3,9,16,17,26,27,30–67 and in vivo stud-
ies.10,15,34,68–70 In the past 10 years, growing evidence 
suggests a relationship between energy loss in the 
TCPC and Fontan hemodynamics47,59–62,69 and exercise 
tolerance.63,66 To date, the influence of energy loss on 
other well-known complications such as protein-losing 
enteropathy, plastic bronchitis, or liver fibrosis/cirrhosis 
has not been studied.
Energy Loss Within the TCPC
The theoretical background of mechanical energy in 
human circulation and the methods of calculating and 
comparing energy loss are supplemented in Appendix I 
and II in the online-only Data Supplement. 
Because the TCPC is basically a connection with 
2 T junctions with opposite flow directions, sudden 
changes in velocities and directions of flow around cor-
ners and over decreasing cross-sectional areas (eg, PAs 
and branching) will inevitably lead to energy losses.35,71 
These energy losses are predominantly through viscous 
dissipation (Appendix I in the online-only Data Supple-
ment) in laminar flow, although energy losses can be of 
greater magnitude when turbulent flow (Appendix III in 
the online-only Data Supplement) occurs.2
The intrinsic instability of TCPC flow has been ob-
served in multiple studies.3,22,26,30,31,68,72 With CFD, 
when using steady inflow boundary conditions, a 
highly disorganized and unsteady flow still appeared 
in the area of colliding blood flow from the SVC and 
IVC, extending into the PAs.31 This includes areas of 
flow stagnation, formation of vortices, and the occur-
rence of swirling, helical flow patterns (Videos 1 and 
2 in the online-only Data Supplement) into the PAs 
(Figure 1). Furthermore, these flow phenomena have 
been reported to change with varying cardiac outputs 
and RPA:LPA flow splits (the percentage of total caval 
blood flow to each PA branch). These flow patterns are 
characterized by high undo velocity gradients and are 
therefore highly dissipative, leading to increased ener-
gy loss in the TCPC.3 Furthermore, wall shear stress has 
also been identified as a major contributor of energy 
loss,43 with most energy being dissipated near the PA 
walls26 and the corners of the anastomosis.56 
Some studies have questioned the relevance of the 
energy loss in the TCPC because energy loss is generally 
low (Table) and may only contribute a small part to the 
whole energy loss in the pulmonary circulation.
In 1 study, energy loss in the TCPC during rest repre-
sented only 13% to 20% of energy loss in the pulmo-
nary circulation and only 2% of ventricular power.58,60 
However, others have shown that TCPC resistance is 
highly variable and can be as high as 55% of pulmo-
nary vascular resistance (PVR) in rest and increase up to 
155% of PVR during simulated exercise.47 In a recent 
study by Tang et al66 reporting on TCPC energy loss in 
47 patients during exercise, TCPC resistance index (RI) 
was on average 0.58 Woods Unit (WU) but could be as 
high as 2.23 WU.
Magnitude of Energy Loss
The range of calculated energy losses (in milliwatts) and, 
when available, the values of efficiency, resistance, RI, 
or indexed power loss (iPL) in 3D, patient-specific TCPC 
models are reported in the Table. Explanations of compar-
ing TCPC efficiency using resistance, RI, and iPL are cov-
ered in Appendix II in the online-only Data Supplement. 
Efficiency of the TCPC (ie, the energy of outflowing versus 
inflowing blood [efficiency = energy out/energy in [%], in 
which the difference is caused by viscous energy loss in 
the TCPC) is highly variable between patients and ranges 
between 63% and 98% at rest and 63% to 91% during 
exercise (Table). TCPC RI is also highly variable and ranges 
between 0.05 and 1.6 WU (Appendix II in the online-only 
Data Supplement) at rest and between 0.07 and 3.95 
WU during exercise. To put this in perspective, in patients 
with a Fontan circulation, PVR has been reported to be 
1.9 to 2.8 WU (range 1.0–4.3).47,77 IPL ranged from 0.007 
to 0.122 in resting conditions, showing that iPL can be 
12.2 to 16.7 times higher in the least efficient TCPCs 
compared with the most efficient TCPCs at rest.60,62
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Figure 1. Geometric factors associated with increased energy loss in the TCPC and modifications to reduce energy 
loss in the TCPC. 
Geometric factors associated with increased (upper) and decreased energy loss (lower) are depicted with a simplified, schemat-
ic extracardiac conduit TCPC (see text for further details). The same factors apply for lateral tunnel (LT) TCPCs. Colored arrows 
represent blood flow, and changes from green to red represent an increase in energy loss. When the inferior vena cava (IVC) 
and superior vena cava (SVC) are connected to the pulmonary vasculature directly opposite each other, collision of blood flow 
leads to a highly disorganized flow, with areas of flow stagnation and flow separation and the occurrence of a swirling, helical 
flow into the pulmonary arteries (PAs) (central figure). Upper, Geometric factors associated with increased energy (Continued )
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Factors Influencing Energy Loss in the 
TCPC 
Vessel Size
The effect of vessel size on energy loss has been re-
ported in the TCPC,26,30,61,64,66,78 and is a logical result 
of the law of Hagen‒Poiseuille, which states that with 
a laminar, steady flow, the resistance of flow through 
a blood vessel is inversely proportional to the fourth 
power of the radius.
The effect of small, hypoplastic, or stenotic PAs 
(Figure  1A and 1C) are, together with the Fontan 
pathway diameter (Figure  1B),61 the most important 
geometry factors associated with increased energy 
loss.42,46,50,53,61,79 Pekkan et al42 performed a virtual an-
gioplasty of a short LPA stenosis of 85%, which led to a 
50% decrease of energy dissipation when the stenosis 
was virtually widened. It was also shown that diffuse 
(long-segment) PA stenosis is more dissipative than a 
short stenosis.42 This furthermore highlights the impor-
tance of well-developed PAs because in small PAs blood 
flow velocity will increase, leading to high wall shear 
stress and increased energy loss.30,43,61
Additionally, the effect of conduit sizes in patients 
with an ECC on energy loss has been studied. Hsia et 
al40 modeled 5 conduit sizes from 10 to 30 mm and 
showed decreased energy loss with increasing conduit 
size to 20 mm. However, an increased conduit size of 
30 mm resulted in increased energy loss because of 
increased flow recirculation within the conduit. There-
fore, although small vessels are detrimental in terms 
of energy loss, bigger is not always better. These areas 
of flow stagnation or recirculation increase energy loss 
and may also increase the risk of thrombosis.80
Itatani et al40,48  recommended 16- to 18-mm con-
duits for children 2 to 3 years of age, but whether this 
size was also ideal for adult patients was not investi-
gated. The ideal conduit size will probably be patient-
specific, and efficiency will change while the patient 
grows. The size of the used conduit will likely be lim-
ited by the conduit:IVC ratio because an increase in 
this ratio was associated with increased energy loss 
because of flow separation through expansion of 
flow from the sudden increase in diameter from IVC 
to Fontan tunnel.24 Despite the fact that cardiac cath-
eterization studies often show absent or minimal (≤2 
mm Hg) pressure gradients in patients with Fontan 
tunnel stenosis,81 energy loss from such an obstruction 
may nevertheless be significant and can exceed the 
total energy loss through the lungs. Restoring normal 
diameter with stenting has been shown to dramatically 
reduce this energy loss.82 This example illustrates the 
importance of energy loss as a new, energetic marker 
because management based on pressure gradient can 
be misleading.
A recent study by Restrepo et al64 showed that a 
TCPC inherently becomes more dissipative with age be-
cause it was reported that normalized vessel diameters 
(vessel diameters corrected for body surface area) de-
crease with time. In other words, growth of IVC, SVC, 
RPA, and LPA does not match somatic growth, making 
the TCPC less efficient with aging.
Total Blood Flow and Pulmonary Flow Split
Energy loss in the TCPC will be larger with an increase 
of blood flow, as demonstrated in multiple stud-
ies,21,23,45,46,57,59,74 with energy loss increasing nonlin-
early with an average of 10.5 and 38.9 times baseline 
energy loss with doubled and tripled flow mimicking 
exercise.46 In that study, RI at rest (range 0.25–0.75 
WU) increased nonlinearly (range 0.70-3.40 WU) dur-
ing simulated exercise. In some patients, however, the 
simulated exercise conditions did not represent physi-
ological values.
Pulmonary flow splits are anywhere near 55%:45% 
(RPA:LPA) in healthy humans and are derived from the 
mass ratio of the right and left lungs (ie, more blood 
flows normally through the bigger right lung).17 Early 
in vitro studies with different simplified models have 
shown that the least energy loss is observed with 45% 
to 55% blood flow to the RPA, with increasing en-
ergy loss when flow splits are highly skewed toward 
1 lung.21,23 However, these values only apply for these 
specific models and conditions because models with 
other geometric properties show other optimal flow 
splits, ranging from 30% to 70% RPA flow.26,30,32,46 For 
example, de Zelicourt et al30 showed the least energy 
loss for a 70% RPA flow split because this patient-
specific model had a small LPA. Increased flow through 
this LPA resulted in increased energy loss. Addition-
Figure 1 Continued. loss in the TCPC. The influence of a long or short PA stenosis (A and C) is illustrated, with a long, diffuse 
stenosis leading to more energy loss than a short, discrete stenosis. Together with a small Fontan tunnel (B), these are the 
most important factors associated with increased energy loss. The angle between the SVC and IVC influences the formation of 
swirling, helical flow patterns when angles are small (90 degrees), with improvement when angles are enlarged (150 degrees) 
(D). Lower, Modifications that reduce energy loss in the TCPC. Caval offset toward 1 of the PAs leads to less energy loss by 
avoiding flow collision and leads to the formation of a low-dissipative vortex (green circle), propelling blood flow into the PAs 
(E). Curving of the vena cava toward a PA leads to lower energy loss compared with an offset model without curving. How-
ever, when IVC flow split does not match pulmonary flow toward that PA, some flow has to make a sharp bend, increasing 
energy loss (red arrow) (F). Flaring of the anastomosis leads to reduced energy loss by avoiding dissipative sharp corners (G). 
The area-preserving Y graft allows for balanced hepatic blood flow split and is associated with reduced energy loss (H). TCPC 
indicates total cavopulmonary connection.
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ally, Whitehead et al46 reported increased energy loss 
for most patients when flow toward the LPA increased 
because in most patients the LPA is smaller than the 
RPA. However, in some patients, the effect of altering 
pulmonary flow split only had a minor effect on energy 
loss, and in others increasing LPA flow split resulted 
in decreased energy loss. In these latter patients, rela-
tive RPA hypoplasia was present. The pulmonary flow 
split in patients is therefore, when assuming equal PVR 
in each lung, predominantly caused by PA size, with 
most blood flowing through the biggest PA.79 In oth-
er words, blood flow follows the path of least resis-
tance, leading to skewed pulmonary flow splits when 
PA stenosis is present. Intuitively, in the ideal situation, 
total caval blood flow needs to be proportionally dis-
tributed over both pulmonary vascular beds. Restoring 
Table. Energy Loss in Realistic, Patient-Specific 3-Dimensional Models
Study Year Method
TCPC
Models (n)
Flow
(L/min)
Energy Loss
(mW)
Efficiency %
(Energy Out/
Energy In)
Resistance
Index
Indexed
Power Loss
Bove39 2003 CFD 2LT, 2ECC 2.29 4.1–56.6 — — —
Miggliavacci73 2003 CFD 4LT, 2ECC 2.28 15–55 — — —
Hsia40 2004 CFD 3LT, 6ECC 1.65 — 89–91 — —
Pekkan31 2005 CFD, IVT 1IA 1–3 10–270 — — —
de Zelicourt30 2005 CFD 1IA 1–3 15–210 — — —
Pekkan42 2005 CFD 1ECC 2.6 15–230 — — —
Marsden45 2006 CFD 2ECC 2.16–6.24 6.7–13.9
(19.5–169.4)
75–93 (69–91) — —
de Zelicourt9 2006 CFD, IVT 2ECC 2–4 5–28 (34–70) — — —
Whitehead46 2007 CFD 9IA, 1ECC 2.37–5.1 CI, 
×2–3
5–20 (40–1200)* — 0.25–0.75 
(0.4–3.4)*
—
Sundareswaran47 2008 CFD 10ECC, 6IA 2–10.5 — — 0.10–1.08
(0.13–2.65)
—
Marsden49 2009 CFD 2ECC, 2Y 1.9–5.6 — 87–90 (76–87) — —
Marsden50 2010 CFD 6ECC 1.6–3.8 CI, x2–3 — 74–96 (63–93) — —
Baretta51 2011 CFD 2ECC, 1Y 2.6 CI 1.09–4.80 91–96 — —
Haggerty54 2012 CFD 1ECC, 3Y 2.6–3.3 1.3–5.1 — 0.18–0.35 —
Yang74 2012 CFD 8Y, 11ECC 1.3–2.5, x2–3 1.8–8.2
(2.9–32.5)
— — —
Ding56 2013 CFD 6ECC NS 5.5–16* — — —
Haggerty57 2013 CFD 5Y, 10ECC 3.0–3.8 CI, x2-3 — — 0.15–1.60 
(0.32–3.95)
—
Hong75 2014 CFD 1ECC, 1LT NS 4.13–10.67 95–98 — —
Sun76 2014 CFD 4ECC 2.48 4.5–13 81–95 — —
Tang61 2013 CFD, IVT 1ECC 2.54 3.8–6.9 — — —
Honda69 2014 Catheterization 7ECC, 1IA, 1LT NS 5.3–17.8 63–93 — —
Haggerty60 2014 CFD 64IA, 33ECC 2.89–3.10 CI — — 0.05–0.66 0.007–0.117
Bossers59 2014 CFD 15LT, 14ECC 3.2–5.3 CI Mean 1.4–3.2/m2
(2.8–15.3/m2)
— Mean 0.06–0.16
(0.07–0.28)
-
Khiabani63 2014 CFD 21IA, 9ECC 2.6–4.8 CI — — — Mean 0.04–0.05
Haggerty62 2015 CFD 25IA, 5ECC 3.2 CI — — — 0.01–0.12
Restrepo64 2015 CFD 36LT, 12ECC 3.0–3.3CI — — — Mean 0.05–0.10
Cibis70 2015 4D MRI 2LT, 4ECC NS Mean 0.56 — — —
Trusty65 2016 CFD 30Y, 30ECC/
LT
1.57–2.07 — — Mean 0.56–1.51† —
Tang66 2017 CFD 33LT, 14ECC Exercise, NS — — Mean 0.58 Mean 0.05
Values are reported in ranges unless specified. Values in exercise conditions or simulated flow conditions >4 L/min are in parentheses. 4D MRI indicates four-
dimensional magnetic resonance imaging; CFD, computational fluid dynamics; CI, cardiac index; ECC, extra cardiac conduit; IA, intraatrial lateral tunnel (after Hemi-
Fontan); IVT, in vitro; LT, lateral tunnel (after Glenn); and NS, not specified.
*Estimation of values from published charts or graphics.
†Resistance (not indexed). 
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PA diameter will restore a more balanced pulmonary 
flow split.42
Caval Flow Split
The previously mentioned studies stressed the impor-
tance of geometry (PA sizes) on optimal pulmonary 
flow split. In humans, IVC:SVC flow split changes from 
51%:49% at birth, 45%:55% in children at 2.5 years 
of age, to the adult value of 65%:35% at 6.6 years of 
age.83 Furthermore, lower limb exercise will predomi-
nantly increase IVC flow with ≤160%.84,85 The effect of 
respiration on caval blood flow has also been reported, 
with IVC flow increasing with ≤60% to 87% during 
inspiration.20,84 The influence of inspiration on SVC flow 
is less clearly established, varying from no increase in 
SVC flow to increase of flow with ≤90%.20,84 Hjort-
dal et al20 showed that in resting conditions, the caval 
flow split (IVC:SVC) was ≈70:30 during inspiration and 
40:60 during expiration. During exercise, this ratio was 
79:21 during inspiration and 64:36 during expiration.85 
Therefore, overall, but especially during lower limb ex-
ercise and inspiration, most blood will enter the TCPC 
via the IVC. An optimal connection of the IVC to the 
PAs will therefore be of great importance. For example, 
Ensley et al22 modeled a connection in which the IVC 
was curved toward the RPA and the SVC toward the 
LPA. This resulted in low energy loss when pulmonary 
flow split to the RPA matched the caval flow split (ie, 
60% IVC flow and 60% RPA flow). With lower RPA 
splits, energy loss increased because blood had to make 
a sharp bend from the curved IVC toward the LPA. A 
connection as such may be clinically unreliable because 
PVR can possibly change, influencing TCPC efficiency. 
For this same reason, connecting the IVC to a smaller 
LPA, while carrying the majority of flow, will likely not 
be the most efficient connection because blood flow 
has to be pushed through a smaller PA or make a sharp 
bend toward the RPA.
Proposed TCPC Modifications to 
Minimize Energy Loss
Offset IVC Versus SVC
The influence of an offset (Figure 1E) between the IVC 
and SVC connection has been studied to avoid the head 
collision of SVC and IVC flows, which has been shown 
to lead to highly disorganized secondary flow patterns, 
increasing energy dissipation.21,22,25,29,68 Offsetting the 
venae cavae 1.0 to 1.5 diameters apart decreases en-
ergy loss ≤50% and has been repeatedly tested as the 
most efficient connection,17,21,29,35,38 with even further 
reduction when the anastomosis site on the RPA is en-
larged.35,39 Such an offset leads to the formation of a 
beneficial, low-dissipative vortex between the IVC and 
SVC anastomosis, propelling their flow toward the re-
spective PAs.15,21,22,25,27
Anastomosis Shape
Furthermore, the addition of curving (Figure 1F) or flaring 
(Figure 1H) of the anastomosis was investigated, show-
ing that flaring of the IVC and SVC anastomosis, thereby 
avoiding dissipative sharp corners,14,71 on all sides can re-
duce the energy loss with another 68% and was more 
efficient than a curvature of the SVC and IVC toward 
one PA.22,23 The angle between the IVC and SVC connec-
tion and the shape of the anastomosis, a slot-like inci-
sion versus an oval excision, have been tested and had 
a significant influence on measured energy loss in those 
models, with ≤75% less energy loss when increasing the 
IVC-SVC angle from 90 to 150 degrees (Figure 1D), and 
≤32% less energy loss over an oval-shaped excision ver-
sus a slot-like incision.28,56 The avoidance of sharp cor-
ners and large differences in cross-sectional areas have 
been emphasized to maximize energy efficiency.71
Besides previously mentioned factors, multiple other 
modifications have been proposed for improving TCPC 
efficiency while keeping adequate hepatic flow distri-
bution (HFD) to both lungs. Soerensen et al86 proposed 
a so-called OptiFlo connection, in which both SVC and 
IVC were split toward both PAs, and this was shown to 
be 42% more efficient compared with the offset model. 
However, clinical implementation was considered to be 
difficult because of anatomic constraints and the need 
for large areas of non-native tissue. To address those 
drawbacks, the Y graft was introduced (Figure 1G).49 Al-
though the Y graft showed decreased energy loss com-
pared with the T-junction TCPC in that study, a recent 
study of 30 implanted Y grafts showed that the TCPC re-
sistance, including the Y graft, was ≈3 times higher than 
traditional ECC or lateral tunnel TCPCs at rest and during 
exercise conditions, making this commercially available Y 
graft inferior to the traditional TCPCs.65,87 The main rea-
son for this adverse result was the use of commercially 
available Y grafts, where the diameters of the 2 branches 
of the Y graft were half the diameter of the base. This ef-
fectively reduces the cross-sectional area with 50% and 
therefore acts as a long-segment obstruction. The use of 
area-preserving Y grafts should give better results and is 
a promising area for future research.74 
A flow divider has also been tested in a CFD model, 
in which a flow-dividing device is placed inside the nor-
mal Fontan tunnel to mimic the effect of a Y graft and 
has been shown to reduce energy loss.88
HEPATIC FLOW DISTRIBUTION
Besides the importance of an energy-efficient TCPC, 
balanced HFD is needed to prevent the formation of 
pulmonary arteriovenous malformations in the hepatic 
factor-deprived lung. Dasi et al52 identified caval offset-
ting as the main factor associated with unbalanced HFD 
in patients with an ECC because the SVC flow creates a 
momentum barrier for the IVC flow to cross toward the 
D
ow
nloaded from
 http://ahajournals.org by on September 18, 2018
Rijnberg et al Energetics of Blood Flow in Cardiovascular Disease
ST
AT
E 
OF
 T
HE
 A
RT
May 29, 2018 Circulation. 2018;137:2393–2407. DOI: 10.1161/CIRCULATIONAHA.117.0333592400
other PA, and this has subsequently been identified as 
one of the most important factors influencing HFD.60,61 
Therefore, offsetting of the IVC is faced with a trade-
off situation between reducing energy loss, on the one 
hand, and unbalanced HFD, on the other hand. Pulmo-
nary flow split also has been found to be correlated with 
HFD.52,60,61 Therefore, these data suggest that clinicians 
should consider a low threshold for intervention when 
factors associated with unbalanced pulmonary flow split, 
most important PA stenosis,61,79 are present because of 
its association with increased energy loss and unbal-
anced HFD. Pulmonary flow split has also been identified 
as the most important factor influencing HFD in patients 
with intraatrial lateral tunnel (after Hemi-Fontan). This is 
explained by increased mixing of hepatic and SVC blood 
flows in these patients, contrary to patients with an ECC, 
before flow enters the pulmonary circulation, leading to 
a strong correlation between HFD and pulmonary flow 
split (eg, if more blood flows through the right lung, then 
less hepatic blood flows through the left lung). Further-
more, Ding et al56 illustrated that increasing the angle 
between RPA and IVC from 45 to 75 degrees improved 
HFD toward the RPA. In other words, curving (Figure 1F) 
of the IVC toward the LPA reduced HFD toward the RPA 
in this model. Also, an increase of the angle between the 
Fontan tunnel and the SVC has been shown to correlate 
with unbalanced HFD in patient-specific TCPC models.61 
However, Ding et al56 investigated this Fontan tunnel-
SVC angle experimentally in a TCPC CFD model, and 
although a decreased angle (Figure 1D) led to increased 
energy loss because of helical flow formation, a change 
of angle did not affect HFD.56 This illustrates that the in-
fluence of certain geometric factors on HFD is patient-
specific, emphasizing the need for patient-specific virtual 
modeling.54,80
However, to date it is not known what the minimum 
amount of hepatic flow is to prevent the formation of 
pulmonary arteriovenous malformations. Quantifica-
tion of HFD in large, longitudinal follow-up series using 
4D flow MRI10 or CFD simulations52 should provide an-
swers to this question. The answers will help in choos-
ing the best surgical options created with virtual sur-
gery with minimal energy loss while only providing the 
necessary, minimal amount of hepatic flow. Although 
the use of novel Y grafts also aimed to induce more 
balanced HFD,74 first results show highly variable HFD 
related to multiple geometric and hemodynamic fac-
tors, including pulmonary flow split and SVC position, 
emphasizing the need for patient-specific surgical plan-
ning when using these grafts.65
Limitations of Energy Loss Assessment
CFD Studies
CFD has been used extensively in the past 3 decades to 
model the hemodynamics and efficiency of the TCPC, 
first in highly simplified symmetrical cross-like models 
and later with advances in computer power and mod-
eling possibilities in 3D patient-specific, image-based 
TCPC geometries (Table). The necessary steps for a CFD 
simulation and the drawbacks and challenges of these 
steps in CFD modeling have been written about in detail 
in previous studies.89 Boundary conditions have to be set 
accurately, and assumptions such as rigid vessel walls,44,90 
steady versus pulsatile inflow conditions,38,55,60,67 and the 
influence of respiration45 have been studied and can 
change conclusions. For example, many studies have as-
sumed a steady flow of venous blood from the vena 
cava to the PAs because of an absent right ventricle. 
However, flow in the IVC can increase with ≤87% dur-
ing inspiration in patients with an TCPC,20,84,85 and the 
contribution of this unsteady inflow or pulsatility on 
calculated energy loss differs between patients.55 It has 
been demonstrated that IVC flow pulsatility changes 
significantly when changing from breath-held to free-
breathing MRI flow acquisitions, emphasizing the in-
fluence of respiration on flow.84 Therefore, by limiting 
the evaluation by using steady flow assumptions, the 
reported energy loss can be different among patients, 
and this difference can affect the reported conclusions. 
In other words, although significant advances have been 
made, the capability of a CFD model to compute realis-
tic pressure and velocity fields in the TCPC depends on 
the accuracy and precision of the generated geometry 
and mesh, applied boundary conditions, and validity of 
the assumptions being made.
Besides that, large validation studies and larger se-
ries correlating CFD-derived parameters to clinical out-
comes are needed. The capability of predictive mod-
eling to improve outcome, which is one of the main 
advantages of CFD modeling in which clinicians can vir-
tually test interventions or different surgical geometries 
in a patient-specific manner to determine the optimal 
treatment, needs to be confirmed in large series before 
clinical implementation can be considered.91
In Vitro Studies
Although in vitro modeling plays an important role in 
the research of TCPC energy loss, it should be realized 
that the early models, which demonstrated the im-
portance of geometric factors such as caval offsetting 
and flaring on energy loss, included highly simplified, 
symmetrical, cross-like rigid tubes with uniform diam-
eters.14,21–24,26–28,78 Implementing more physiological 
features in these models, such as unequal vessel diam-
eters and nonplanarity (ie, PAs do not lie in a strictly 
left to right plane) of the PAs, significantly changed 
fluid hemodynamics.26 Besides the limiting, simplified 
geometry, most models also used steady inflow condi-
tions and rigid materials influencing reported conclusi
ons.38,44,55,67,90 Patient-specific MRI-based TCPC mod-
els have led to more accurate models, although these 
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models still use rigid material and steady inflow condi-
tions.9,30,34 Recently, a promising in vitro model has been 
introduced that uses a patient-specific, MRI-derived 
compliant TCPC model based on the patient-specific 
compliance value and uses condition-specific (breath-
held, free breathing and exercise), real-time, phase-
contrast MRI-derived flow waveforms as inflow con-
ditions.92 First results have shown and quantified the 
effect of respiration and exercise on energy loss and 
demonstrated that the effect of these parameters was 
highly patient-specific. Therefore, it is emphasized that 
future CFD models should use patient- and condition-
specific boundaries.
In Vivo Studies
Only a limited amount of in vivo studies has reported on 
calculated energy loss in the TCPC.69,70,93 In vivo energy 
loss studies can be subdivided into studies using cath-
eterization or 4D MRI-derived data to calculate energy 
loss. One advantage of these in vivo methods is that the 
number of assumptions to obtain the energy losses is 
limited compared with CFD modeling.
Catheterization Studies
The capability of the catheterization method to ac-
curately capture the highly dynamic and 3D flow and 
pressure fields is limited. In a recent in vivo study,69 
averaged pressures and velocities were used at the 
inlet and outlet sections, which have been shown to 
overestimate energy loss with 18%,94 and are inher-
ently associated with measurement errors because the 
position and size of the catheter inside the vessel will 
influence measured pressure and velocity values. For 
example, when a swirling, helical flow pattern is pres-
ent, the central pressure measurement may not reflect 
the true pressure. Also, when calculating the cross-sec-
tional area of the vena cava and PAs, which is needed 
to calculate flow from velocity, vessels are assumed to 
be circular, which is not necessarily true. Furthermore, 
the possibility to calculate these losses during exercise 
is limited because catheterization with indwelling cath-
eters77 is not a routine practice.
4D Flow MRI Studies
One in vivo study used 4D flow MRI to calculate energy 
loss in the TCPC using the viscous dissipation method 
(Appendix I in the online-only Data Supplement), with 
an average energy loss of 0.56±0.28 milliwatts.70 To 
date, 2 studies calculated kinetic energy using 4D flow 
MRI in the TCPC, with an average loss of 31±20% in 1 
study93 but an increase in kinetic energy of 142% in the 
other. In this latter study, the increase of kinetic energy 
is explained by a 50% decrease of the combined cross-
sectional area of the SVC and IVC compared with the 
PAs.95 It should be noted that kinetic energy is only part 
of the energy equation (Appendix I in the online-only 
Data Supplement) and does not represent total energy 
loss. Although 4D flow MRI is a promising noninvasive 
technique that can be easily implemented in clinical 
care, spatial resolution (ie, the size of the voxels in mm3) 
is a major issue because this has been shown to be the 
limiting factor in accurately calculating energy loss (Ap-
pendix I in the online-only Data Supplement). However, 
although underestimating absolute true energy loss 
because of limited spatial resolution, the relative per-
formance of the TCPC among subjects remains intact 
when compared with CFD values, indicating that com-
parison of subjects is still possible with 4D flow MRI.70
Clinical Relevance of Energy Loss  
in the TCPC
To date, increased energy loss in the TCPC has been 
linked to (1) reduced exercise capacity, and (2) altered 
cardiac parameters and increased central venous pres-
sure (CVP).
Exercise Capacity and Energy Loss in the TCPC
Exercise capacity is generally limited in patients after 
a TCPC, with a peak oxygen consumption (Vo2 max) 
of only 65% of expected at 12 years of age, which 
gradually worsens with increasing age.13,96 However, 
there is considerable variability in exercise tolerance, 
varying from 19% of predicted Vo2 max to even su-
pranormal values, with only 28% of patients having a 
normal value.13
Although the lower exercise tolerance in patients 
with a Fontan circulation is multifactorial, including 
chronotropic incompetence, arterial desaturation, dia-
stolic dysfunction, peripheral factors (eg, lean muscle 
mass), and SV stroke volume, the latter (stroke volume) 
has been marked as the most important factor, explain-
ing ≤73% of variance in Vo2 max among patients.
13,19,77
The resting cardiac output (CO) in a patient with 
a Fontan circulation is generally 60% to 70% of pre-
dicted, and the ability to increase CO during exercise 
is severely impaired because of preload deprivation. 
The role of PVR as the main factor controlling CO by 
limiting preload has been well recognized.97 The TCPC 
resistance can be seen as a separate resistance in series 
with the PVR. Because of the clear role of PVR on the 
disability to increase CO, the energy loss or resistance 
in the TCPC has been studied as a possible contributing 
factor of reduced CO and therefore reducing exercise 
tolerance via the same mechanism as PVR does.
In healthy adults, PVR has been shown to decrease 
≤50% at exercise.98 This means that the TCPC resis-
tance (Appendix II in the online-only Data Supplement), 
although possibly of minor influence in resting condi-
tions, can be the predominant bottleneck during exer-
cise. In other words, the focus of PVR as the most im-
portant factor of influence on preload can shift during 
exercise conditions toward the TCPC resistance in some 
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patients because the TCPC resistance has been shown 
to increase exponentially with exercise.46
The only study to date showing a correlation be-
tween energy loss and exercise capacity in patients with 
TCPC is by Khiabani et al.63 In this study, 30 patients 
performed metabolic exercise testing, and flow rates 
were collected during rest and exercise using MRI. A 
significant negative linear correlation (r=‒0.6) was seen 
among iPL, Vo2 max, and work (per kg). These results 
were later confirmed in an extension of this study in 
47 patients.66 In that study, the TCPC diameter index—
an index capturing the minimal diameters of all the 4 
TCPC vessels (IVC, SVC, RPA, and LPA) in 1 parameter—
showed a significant moderate correlation (r=0.468) 
with Vo2 max.
In a study by Bossers et al,59 MRI data were obtained 
from 29 patients during rest and during dobutamine in-
fusion mimicking exercise. CFD models were construct-
ed, and to simulate lower body exercise, 2x IVC flow 
was simulated. In this study, using RI and energy loss 
normalized by body surface area, no correlation was 
found between energy loss and exercise performance 
parameters. It has been suggested that normalizing en-
ergy loss with body surface area is the reason this study 
found no difference in exercise capacity because this 
parameter is highly flow-dependent.99
Cardiac Parameters and Energy Loss in the TCPC
In the last decade, a number of studies have reported 
correlations between energy loss within the TCPC and 
cardiac parameters and CVP. 
In a lumped parameter model, Sundareswaran et 
al47 showed a weak (r=‒0.36) negative linear corre-
lation between TCPC resistance and CO, with an ex-
pected CO decrease of 8.8% for each 10% increase in 
TCPC resistance. This finding was later confirmed in the 
largest series to date using CFD modeling, in which iPL 
was inversely correlated with cardiac index (r=‒0.21) 
and systemic venous return (r=‒0.31).60 Additionally, a 
significant, moderate inverse relationship between iPL 
and end diastolic (r=‒0.48), end systolic (r=‒0.37), and 
stroke volumes (r=‒0.37) was reported. Furthermore, a 
positive correlation was found between iPL and time to 
peak filling rate (r=0.67).62
Sundareswaran et al47 reported both an increase 
in ventricular-vascular coupling mismatch and an in-
crease of CVP with increasing TCPC resistance. CVP 
increased with 6.4% for each 10% increase in resis-
tance. In a mathematical study using failing Fontan 
hemodynamics, 57% of the increase in CVP in pa-
tients with failing Fontan,  defined as New York Heart 
Association classes III and IV, supraventricular tachyar-
rhythmias, persistent effusions unresponsive to diuret-
ic therapy, and hypoalbuminemia, could be ascribed 
to TCPC resistance and the remaining increase to a 
rise of atrial pressure.100
In the only in vivo study to date correlating TCPC 
energetics with cardiac parameters, a positive correla-
tion was found between energy loss measured during 
catheterization and time constant Tau and systolic dPdt 
(contractility), reflecting diastolic and systolic function, 
respectively. However, no correlation between energy 
loss and systemic venous flow was found.69 
These data suggest the importance of energy loss 
in the TCPC on hemodynamics by reducing ventricular 
preload, preload reserve, and thereby CO, and possibly 
by influencing diastolic function.
FUTURE DIRECTIONS AND 
CONCLUSIONS
In the past 3 decades, the factors associated with the 
energetics in the TCPC and the potential role of this 
energy loss on Fontan outcome has become more obvi-
ous. However, although an increasing amount of stud-
ies connect energy loss with cardiac parameters and 
exercise capacity, evidence is mainly based on small (n 
≤ 30) series, and some have conflicting results. Further-
more, to date, no studies connect complications asso-
ciated with failing Fontan physiology, such as protein-
losing enteropathy, plastic bronchitis, or liver cirrhosis 
with energy loss in the TCPC. Larger, multicenter series 
are needed, and long-term follow-up should definitely 
clarify the role of energy loss in the TCPC on long-term 
outcomes and can thereby possibly predict adverse out-
comes early. Additionally, to date, energy loss is almost 
exclusively calculated via CFD modeling, and the capa-
bility of this method to reflect reality depends on the 
accuracy of the boundary conditions and the validity of 
underlying assumptions.
4D flow MRI can be of important complementary 
value by offering in vivo, noninvasive acquisition of ac-
curate time-resolved 3D velocity vector fields (Videos 1 
and 2 in the online-only Data Supplement), after which 
energy loss, kinetic energy, turbulent kinetic energy, and 
areas of increased wall shear stress in the TCPC can be 
calculated (Figure 2). However, main limitations include 
a long scan time, noisy velocity data, and limited spatial 
and temporal resolution. Increasing resolution to better 
capture 3D flow and velocity gradients will decrease sig-
nal to noise ratio and increase scanning time, and con-
sequently its clinical use is now limited. New sequences 
for accelerating acquisition of data are developed and 
can reduce scan time, however, at a possible cost of 
reduced accuracy. For implementation of 4D flow MRI 
techniques in the patient with a Fontan circulation, op-
timal scan parameters and protocols have to be deter-
mined, in which compromises between resolution and 
clinical acceptable scanning times have to be made.8
Large 4D flow MRI series will be needed and should 
ideally put calculated TCPC resistance in the context 
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of patient-specific PVR, both at rest and during exer-
cise conditions. Furthermore, large 4D flow MRI series 
should be obtained and used to validate CFD models 
in capturing the sometimes highly 3D chaotic flows, 
which to date have only been performed in a limited 
number of patients with a Fontan circulation.34,60 Fur-
thermore, confirmation of the impact of energy loss on 
clinical outcome based on in vivo data with 4D flow 
MRI will likely increase confidence in computed results 
from CFD studies and may accelerate the clinical imple-
mentation of patient-specific CFD models in the future.
In conclusion, an extensive amount of studies has 
shown that the efficiency of the TCPC is highly vari-
able and therefore provides room for improvement. The 
TCPC resistance will likely be an important additional 
parameter, complementary to factors such as PVR, in 
determining outcomes in patients with a Fontan circu-
lation. Therefore, via the same rationale for why efforts 
have been made to decrease PVR in patients with a 
Fontan circulation, surgical modifications and patient-
specific TCPC planning will aim to improve outcomes 
by reducing TCPC resistance and thereby increasing 
TCPC efficiency.
When a more definitive correlation between energy 
loss in the TCPC and adverse outcomes such as protein-
losing enteropathy, plastic bronchitis, liver cirrhosis, 
and exercise intolerance has been clarified, knowledge 
about the factors explaining the variability of the TCPC 
Figure 2. Visualization of abnormal blood flow patterns in the TCPC with 4D MRI. 
Unprecedented possibilities of visualizing blood flow patterns in vivo in patients with a Fontan circulation by using 4D flow 
MRI. The schematic TCPC with zero offset (Figure 1) is shown for orientation (A). Images show the TCPC of an 18-year-old 
patient with tricuspid atresia with a nonfenestrated 16-mm extracardiac conduit with offset, leading to predominant inferior 
vena cava (IVC) flow toward the left pulmonary artery (LPA) (B through L). The orientation of the swirling blood flow within 
the crux of the TCPC and the location of the cross-sectional planes are shown (B). Streamlines and particle tracings are shown 
from a left anterior oblique view (C and D). Pathlines with velocity coding show areas of slow (blue) blood flow in the SVC and 
increased (red) velocities inside the tunnel and the distal PAs, with the formation of a swirling flow into the right pulmonary 
artery (RPA). Also, a swirling inflow from the vena anonyma (not included) into the proximal part of the SVC is noted (C). Par-
ticle tracing analysis shows the differential contribution and interaction between IVC and superior vena cava (SVC) blood flow. 
SVC flow is pushed anteriorly into the helical flow extending into the RPA. Additionally, SVC blood flows exclusively toward 
the RPA, and predominant SVC flow to the lower right segmental pulmonary artery is shown (D). The flow vectors are shown 
and visualized for velocity (E through H) and for the angle to the normal (the normal is the vector perpendicular to the plane) 
(I through L). Although most of the flow in the IVC, SVC, and LPA shows laminar flow with no angle (ie, blood flows parallel 
to the vessel wall), angles ≤70 degrees are shown in the RPA at the site of the helical flow. These abnormal flow patterns are 
associated with increased energy loss.7 It is important to note that blood flow qualification (visualization) is only 1 of the many 
possibilities of 4D MRI. The acquired 4D flow data (velocity field) can also be used to calculate quantitative haemodynamic 
parameters based on these in vivo velocity data (in contrast with CFD) among which are energy loss and wall shear stress (not 
shown here). The figures were morphed for better display without editing the flow within the TCPC. 4D indicates four dimen-
sional; MRI, magnetic resonance imaging; and TCPC, total cavopulmonary connection.
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efficiency and the possibility of virtual surgery using 
CFD predictive modeling will likely guide future man-
agement in a patient-specific manner.
This review illustrates the important concept of ad-
verse energetics in the TCPC in patients with a Fontan 
circulation. However, the same principles of visualiza-
tion and quantification of 3D blood flow data and the 
adverse effects of distorted blood flow on energetics 
are promising in many cardiovascular diseases, includ-
ing ischemic and dilated cardiomyopathies, valvular 
heart disease, aortic disease, heart failure, and other 
congenital heart disease. Future studies should clarify 
the role of these new parameters in various cardiovas-
cular diseases to determine its potential use in clinical 
care.
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